Caredx announces appointment of suresh gunasekaran to board of directors

South san francisco, calif.--(business wire)--caredx, inc. (nasdaq: cdna), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients, today announced the appointment of suresh gunasekaran to its board of directors. suresh currently serves as president and chief executive officer at ucsf health, an internationally renowned health system for providing highly specialized an.
CDNA Ratings Summary
CDNA Quant Ranking